8121
-
Infection and Drug Resistance
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Real benefits for authors, including fast-track processing of papers.
Infection and Drug Resistance
(245,252) Views
Editor in Chief Professor Suresh Antony
1178-6973
ReviewCurrent strategies for the prevention and management of central line-associated bloodstream infections
Zhuolin Han, Stephen Y Liang, Jonas Marschall
Infection and Drug Resistance 2010, 3:147-163
23 November 2010
Review
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
Josep Quer, Maria Buti, Maria Cubero, et al
Infection and Drug Resistance 2010, 3:133-145
23 November 2010
Review
Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
Martha K Daddario, Jennifer K Hagerman, Michael E Klepser
Infection and Drug Resistance 2010, 3:123-132
28 October 2010
Review
Multidrug and extensively drug-resistant tuberculosis from a general practice perspective
BM Yashodhara, Choo Beng Huat, Lakshmi Nagappa Naik, et al
Infection and Drug Resistance 2010, 3:115-122
22 October 2010
Review
Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy
Charlotte Charpentier, Laurence Weiss
Infection and Drug Resistance 2010, 3:103-114
13 October 2010
Review
Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
Andres Beiras-Fernandez, Ferdinand Vogt, Ralf Sodian, et al.
Infection and Drug Resistance 2010, 3:95-101
30 August 2010
Review
Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts
Johanna M Porter-Kelley, Joann Cofie, Sophonie Jean, et al
Infection and Drug Resistance 2010, 3:87-94
19 August 2010
Review
Methicillin-resistant Staphylococcus aureus in HIV-infected patients
Alicia I Hidron, Russell Kempker, Abeer Moanna, et al
Infection and Drug Resistance 2010, 3:73-86
06 August 2010
Review
The use of anti-tuberculosis therapy for latent TB infection
Justin T Denholm, Emma S McBryde
Infection and Drug Resistance 2010, 3:63-72
21 July 2010
Original Research
Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change
J Mebis, H Jansens, G Minalu, et al
Infection and Drug Resistance 2010, 3:53-61
28 July 2010
Review
Role of posaconazole in the treatment of oropharyngeal candidiasis
Voichita Ianas, Kathryn R Matthias, Stephen A Klotz
Infection and Drug Resistance 2010, 3:45-51
28 June 2010
Review
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial
Lorenzo Aguilar, María-José Giménez, José Barberán
Infection and Drug Resistance 2010, 3:35-43
18 June 2010
Review
Prevention strategies for antimicrobial resistance: a systematic review of the literature
Whitney P Caron, Shaker A Mousa
Infection and Drug Resistance 2010, 3:25-33
21 May 2010
Review
Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection
Lisa M Chirch, Roy T Steigbigel
Infection and Drug Resistance 2010, 3:15-23
26 April 2010
Review
Emerging agents to combat complicated and resistant infections: focus on ceftobiprole
César Bustos, Jose L Del Pozo
Infection and Drug Resistance 2010, 3:5-14
22 April 2010
Case report
Respiratory failure caused by intrathoracic amoebiasis
Toshinobu Yokoyama, Masashi Hirokawa, Yutaka Imamura, et al
Infection and Drug Resistance 2010, 3:1-4
11 March 2010
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
